Aspire Biopharma Holdings, Inc. has announced a corporate name change to Aspire-Lakewood Holdings, Inc., effective upon the filing of a Certificate of Amendment to the Company’s Certificate of Incorporation with the Secretary of State of Delaware. The company stated that the name change reflects its evolving business strategy and operations. Following the acquisition of Dura Control Systems Corp., the company has scaled into a high-volume, diversified enterprise, and the new name better aligns its corporate architecture with this expanded business focus.
The ticker symbol for the company’s common stock, currently listed on The Nasdaq Capital Market, will remain unchanged. The company’s shares of common stock will continue to be listed and traded on Nasdaq. Stockholders holding shares in book-entry form or through a bank, broker, or other nominee are not required to take any action in connection with the name change.
The name change was approved by the Company’s board of directors and stockholders in accordance with Section 242 of the General Corporation Law of the State of Delaware. The company noted that the name change does not affect the rights of the Company’s stockholders, and stock certificates reflecting the prior corporate name will continue to be valid.
Aspire-Lakewood Holdings, Inc. operates through its subsidiary, Dura Control Systems Corp. (DCSC), a designer and manufacturer of highly engineered automotive and industrial control systems. DCSC maintains a strong powertrain agnostic product portfolio that includes mechatronic actuators, human machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The company operates 11 manufacturing facilities globally and serves as a tier one automotive supplier to major OEMs and other industrial firms.
